Clinical protocols for nanopharmacokinetics assessment

Manandhar, Suman; Sankhe, Runali; Kumar, B. Harish; Pai, K. Sreedhara Ranganath

doi:10.1016/b978-0-323-85050-6.00001-3

Cited by 2 publications

References 44 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

The role of Shigella spp. in propagating bacillary dysentery in humans and the prominence of nanotechnology in disease prevention

Hmar,

Paul,

Sharma

2024

Futur J Pharm Sci

View full text Add to dashboard Cite

Background Shigellosis, also known as bacillary dysentery, is an acute infection of the intestine. The symptoms can vary from mild watery diarrhoea to severe inflammatory bacillary dysentery, which is characterized by fever, intense abdominal cramps, and the presence of blood and mucus in the stools. While the disease typically resolves on its own, it can become life-threatening in immunocompromised individuals or in the absence of adequate medical care. Main body of the abstract Shigella is the primary cause of bacillary dysentery worldwide. It is comprised of four distinct species—S. dysenteriae, S. flexneri, S. boydii, and S. sonnei—each with unique genomic characteristics and disease-causing abilities. Shigella spp. have developed resistance to multiple drugs and have also adapted well to the gut environment over time. They have become well-suited to infecting the human gut epithelial cells and causing dysentery. Consequently, numerous studies have investigated the potential application of nanotechnology in the treatment of shigellosis by leveraging its capability for drug delivery and targeted therapy, thereby improving effectiveness while reducing side effects. Short conclusion It is crucial to maintain ongoing surveillance and develop new strategies to effectively manage this issue. In this review, we shed light on the present comprehension of distinct Shigella spp. and their potential contribution to the pathogenesis of shigellosis, along with their interaction with the gut microbiota. We also provide insight into how nanotechnology may be a major factor in preventing shigellosis in the future.

show abstract

The role of Shigella spp. in propagating bacillary dysentery in humans and the prominence of nanotechnology in disease prevention

Hmar,

Paul,

Sharma

2024

Futur J Pharm Sci

View full text Add to dashboard Cite

show abstract

Mapping the Landscape of Biogenic Nanoparticles in Bioinformatics and Nanobiotechnology

Padhiary,

Roy,

Dey

2024

Advances in Chemical and Materials Engineering

View full text Add to dashboard Cite

The relationship between biogenic nanoparticles, bioinformatics, and nanobiotechnology is investigated in this chapter, with an emphasis on the contribution of artificial intelligence to the advancement of science and technology. There are numerous applications for biological nanoparticles in agriculture, medicine, and environmental cleanup. The chapter emphasizes the significance of thorough investigation, safety concerns, adhering to regulations, and ethical considerations. It also discusses about how AI-powered techniques can be used to make, characterize, and use biogenic nanoparticles, which can lead to new insights based on data, predictive modeling, and personalized methods. Researchers can solve societal demands and promote environmental sustainability and human health by utilizing AI-driven technologies and biogenic nanoparticles through ethical innovation and interdisciplinary collaboration.

show abstract

Clinical protocols for nanopharmacokinetics assessment

Cited by 2 publications

References 44 publications

The role of Shigella spp. in propagating bacillary dysentery in humans and the prominence of nanotechnology in disease prevention

The role of Shigella spp. in propagating bacillary dysentery in humans and the prominence of nanotechnology in disease prevention

Mapping the Landscape of Biogenic Nanoparticles in Bioinformatics and Nanobiotechnology

Contact Info

Product

Resources

About